Annovis Bioinc Stock Today
| ANVS Stock | USD 8.99 1.09 10.81% |
Performance0 of 100
| Odds Of DistressOver 84
|
Annovis BioInc is selling for under 8.99 as of the 18th of April 2024; that is -10.81 percent decrease since the beginning of the trading day. The stock's lowest day price was 8.86. Annovis BioInc has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Annovis BioInc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of March 2024 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 12th of February 2010 | Category Healthcare | Classification Health Care |
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania. Annovis Bio operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. The company has 11.01 M outstanding shares of which 1.5 M shares are presently shorted by private and institutional investors with about 5.68 trading days to cover. More on Annovis BioInc
Moving against Annovis Stock
| 0.54 | MRSN | Mersana Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.49 | GRTX | Galera Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.45 | EOLS | Evolus Inc Financial Report 14th of May 2024 | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Financial Report 9th of May 2024
Annovis Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Annovis BioInc's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Annovis BioInc or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Maria Maccecchini | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Annovis BioInc report their recommendations after researching Annovis BioInc's financial statements, talking to executives and customers, or listening in on Annovis BioInc's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Annovis BioInc. The Annovis consensus assessment is calculated by taking the average forecast from all of the analysts covering Annovis BioInc. | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from Annovis BioInc's historical financial statements, Annovis BioInc may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. Financial strength of Annovis BioInc is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||
Annovis BioInc's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Annovis BioInc's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Annovis BioInc's financial leverage. It provides some insight into what part of Annovis BioInc's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Annovis BioInc (ANVS) is traded on New York Stock Exchange in USA. It is located in 1055 Westlakes Drive, Berwyn, PA, United States, 19312 and employs 6 people. Annovis BioInc is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 110.99 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Annovis BioInc's market, we take the total number of its shares issued and multiply it by Annovis BioInc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Annovis BioInc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 11.01 M outstanding shares of which 1.5 M shares are presently shorted by private and institutional investors with about 5.68 trading days to cover.
Annovis BioInc currently holds about 35.97 M in cash with (39.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.41.
Check Annovis BioInc Probability Of Bankruptcy
Ownership AllocationAnnovis BioInc retains a total of 11.01 Million outstanding shares. Annovis BioInc retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Annovis Ownership Details
Annovis Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Annovis BioInc jumping above the current price in 90 days from now is about 90.01%. The Annovis BioInc probability density function shows the probability of Annovis BioInc stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 4.2081. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Annovis BioInc will likely underperform. Additionally, annovis BioInc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Annovis BioInc to move above the current price in 90 days from now is about 90.01 (This Annovis BioInc probability density function shows the probability of Annovis Stock to fall within a particular range of prices over 90 days) .
Annovis Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Annovis BioInc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Annovis BioInc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Annovis BioInc's value.| Instituion | Recorded On | Shares | |
| State Street Corporation | 2023-12-31 | 23.5 K | |
| Merit Financial Group, Llc | 2023-12-31 | 22.2 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 20.7 K | |
| Susquehanna International Group, Llp | 2023-12-31 | 15.8 K | |
| Two Sigma Securities, Llc | 2023-12-31 | 12.3 K | |
| Jane Street Group, Llc | 2023-12-31 | 12 K | |
| Citigroup Inc | 2023-12-31 | 11.2 K | |
| Dimensional Fund Advisors, Inc. | 2023-12-31 | 11.1 K | |
| Sontag Advisory Llc | 2023-12-31 | 11 K | |
| Vanguard Group Inc | 2023-12-31 | 337.4 K | |
| Adage Capital Partners Gp Llc | 2023-12-31 | 285.3 K |
Annovis BioInc Historical Income Statement
Annovis BioInc Income Statement is one of the three primary financial statements used for reporting Annovis's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Annovis BioInc revenue and expense. Annovis BioInc Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Annovis BioInc's Selling General Administrative is comparatively stable compared to the past year. Gross Profit is likely to gain to about 263.2 K in 2024, despite the fact that Operating Income is likely to grow to (42.8 M). View More FundamentalsAnnovis Stock Against Markets
Picking the right benchmark for Annovis BioInc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Annovis BioInc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Annovis BioInc is critical whether you are bullish or bearish towards Annovis BioInc at a given time. Please also check how Annovis BioInc's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Annovis BioInc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Annovis BioInc Corporate Management
Elected by the shareholders, the Annovis BioInc's board of directors comprises two types of representatives: Annovis BioInc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Annovis. The board's role is to monitor Annovis BioInc's management team and ensure that shareholders' interests are well served. Annovis BioInc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Annovis BioInc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Reid McCarthy | Independent Director | Profile | |
| Cheng Fang | Senior Development | Profile | |
| Melissa Gaines | Senior Operations | Profile | |
| Mark White | Independent Director | Profile |
How to buy Annovis Stock?
Before investing in Annovis BioInc, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Annovis BioInc. To buy Annovis BioInc stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Annovis BioInc. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Annovis BioInc stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Annovis BioInc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Annovis BioInc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Annovis BioInc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Annovis Stock please use our How to Invest in Annovis BioInc guide.
Already Invested in Annovis BioInc?
The danger of trading Annovis BioInc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Annovis BioInc is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Annovis BioInc. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Annovis BioInc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Annovis BioInc is a strong investment it is important to analyze Annovis BioInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Annovis BioInc's future performance. For an informed investment choice regarding Annovis Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Annovis BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy Annovis Stock please use our How to Invest in Annovis BioInc guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Annovis Stock analysis
When running Annovis BioInc's price analysis, check to measure Annovis BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis BioInc is operating at the current time. Most of Annovis BioInc's value examination focuses on studying past and present price action to predict the probability of Annovis BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis BioInc's price. Additionally, you may evaluate how the addition of Annovis BioInc to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Annovis BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis BioInc. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.23) | Return On Assets (1.22) | Return On Equity (5.46) |
The market value of Annovis BioInc is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis BioInc's value that differs from its market value or its book value, called intrinsic value, which is Annovis BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis BioInc's market value can be influenced by many factors that don't directly affect Annovis BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Annovis BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.